Lee Scott Golden
Director; EVP & CHIEF MEDICAL OFFICER · 4 filings · Latest: Oct 9, 2026
Cadrenal Therapeutics, Inc.
PTC THERAPEUTICS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | Apr 2, 2026 | Sale | $67.99 | 829 | $56.4K | 79,115 | |
PTCT | Golden Lee Scott | — | Apr 2, 2026 | Proposed Sale | $67.99 | 829 | $56.4K | — | |
PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | Mar 5, 2026 | Sale | $63.38 | 10,000 | $633.8K | 79,944 | |
PTCT | Golden Lee Scott | — | Mar 5, 2026 | Proposed Sale | $63.38 | 10,000 | $633.8K | — | |
PTCT | Lee Scott Golden | EVP & CHIEF MEDICAL OFFICER | Feb 18, 2026 | Sale | $69.36 | 2,484 | $172.3K | 89,944 | |
PTCT | Golden Lee Scott | — | Feb 18, 2026 | Proposed Sale | $69.36 | 2,484 | $172.3K | — | |
PTCT | Golden Lee Scott | — | Jan 8, 2026 | Proposed Sale | $76.45 | 866 | $66.2K | — | |
PTCT | Golden Lee Scott | — | Jan 7, 2026 | Proposed Sale | $77.48 | 642 | $49.7K | — | |
PTCT | Golden Lee Scott | — | Jan 6, 2026 | Proposed Sale | $76.95 | 1,340 | $103.1K | — | |
PTCT | Golden Lee Scott | — | Apr 2, 2025 | Proposed Sale | $46.95 | 897 | $42.1K | — | |
PTCT | Golden Lee Scott | — | Feb 20, 2025 | Proposed Sale | $50.12 | 962 | $48.2K | — | |
PTCT | Golden Lee Scott | — | Feb 19, 2025 | Proposed Sale | $50.10 | 795 | $39.8K | — | |
PTCT | Golden Lee Scott | — | Jan 8, 2025 | Proposed Sale | $44.50 | 1,198 | $53.3K | — | |
PTCT | Golden Lee Scott | — | Jan 7, 2025 | Proposed Sale | $45.34 | 810 | $36.7K | — |